Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,071 | 614 | 94.3% |
| Travel and Lodging | $630.10 | 2 | 5.4% |
| Education | $32.88 | 2 | 0.3% |
| Unspecified | $0 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,984 | 148 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $1,095 | 20 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,029 | 67 | $0 (2024) |
| PFIZER INC. | $924.66 | 49 | $0 (2024) |
| Janssen Biotech, Inc. | $911.63 | 36 | $0 (2024) |
| Celgene Corporation | $748.03 | 68 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $610.77 | 38 | $0 (2024) |
| GENZYME CORPORATION | $420.47 | 10 | $0 (2024) |
| Allergan Inc. | $370.91 | 27 | $0 (2019) |
| QOL Medical, LLC | $265.64 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,754 | 89 | ABBVIE INC. ($443.41) |
| 2023 | $1,825 | 92 | AbbVie Inc. ($430.87) |
| 2022 | $972.87 | 49 | ABBVIE INC. ($260.21) |
| 2021 | $493.96 | 33 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($145.32) |
| 2020 | $430.62 | 27 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($99.43) |
| 2019 | $1,821 | 120 | AbbVie, Inc. ($534.39) |
| 2018 | $2,899 | 137 | Ironwood Pharmaceuticals, Inc ($870.05) |
| 2017 | $1,537 | 73 | AbbVie, Inc. ($556.28) |
All Payment Transactions
620 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $122.88 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Rare Disease | ||||||
| 11/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/26/2024 | PFIZER INC. | XELJANZ (Drug), INFLECTRA, ABRILADA | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $129.02 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.71 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | PFIZER INC. | XELJANZ (Drug), INFLECTRA, ABRILADA | Food and Beverage | In-kind items and services | $35.51 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.53 | General |
| Category: Neuroscience | ||||||
| 10/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.64 | General |
| Category: Neuroscience | ||||||
| 10/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.61 | General |
| Category: Neuroscience | ||||||
| 10/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.20 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Immunology | ||||||
| 09/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.08 | General |
| Category: Neuroscience | ||||||
| 09/26/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.92 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 527 | 617 | $369,243 | $61,491 |
| 2022 | 15 | 742 | 15,852 | $566,581 | $97,381 |
| 2021 | 13 | 763 | 915 | $614,489 | $89,179 |
| 2020 | 15 | 673 | 22,634 | $547,222 | $96,301 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 209 | 275 | $51,425 | $19,964 | 38.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 80 | 80 | $115,896 | $16,857 | 14.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 76 | 89 | $72,936 | $8,366 | 11.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 65 | 65 | $76,505 | $6,248 | 8.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $13,365 | $4,411 | 33.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $16,632 | $3,004 | 18.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 16 | 22 | $21,780 | $2,633 | 12.1% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 11 | 16 | $704.00 | $8.11 | 1.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 251 | 320 | $52,179 | $23,037 | 44.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 94 | 94 | $150,038 | $20,484 | 13.7% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2022 | 12 | 15,000 | $30,645 | $13,133 | 42.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 88 | 97 | $112,836 | $8,616 | 7.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 86 | 86 | $121,103 | $8,133 | 6.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $9,442 | $4,249 | 45.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 20 | 20 | $24,994 | $3,953 | 15.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 45 | 45 | $9,575 | $3,878 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 29 | $7,015 | $3,097 | 44.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 11 | 17 | $17,865 | $2,233 | 12.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $15,616 | $2,051 | 13.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 30 | $3,684 | $1,817 | 49.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $3,008 | $1,378 | 45.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 13 | 21 | $7,440 | $1,300 | 17.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 18 | 37 | $1,142 | $19.48 | 1.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 235 | 341 | $47,740 | $24,533 | 51.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 80 | 81 | $141,750 | $17,495 | 12.3% |
About Strick Woods
Strick Woods is a Specialist healthcare provider based in Fairfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568454247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Strick Woods has received a total of $11,734 in payments from pharmaceutical and medical device companies, with $1,754 received in 2024. These payments were reported across 620 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($11,071).
As a Medicare-enrolled provider, Woods has provided services to 2,705 Medicare beneficiaries, totaling 40,018 services with total Medicare billing of $344,352. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Fairfield, CT
- Active Since 08/18/2005
- Last Updated 10/30/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1568454247
Products in Payments
- Humira (Biological) $885.55
- XELJANZ (Drug) $875.76
- XIFAXAN (Drug) $798.93
- ZEPOSIA (Drug) $764.17
- RINVOQ (Biological) $558.03
- STELARA (Biological) $514.67
- SKYRIZI (Biological) $484.07
- DUPIXENT (Biological) $479.43
- REMICADE (Biological) $316.74
- LINZESS (Drug) $309.60
- HUMIRA (Biological) $251.02
- Sucraid (Drug) $247.17
- Entyvio (Biological) $242.18
- TREMFYA (Drug) $205.24
- ZENPEP (Drug) $195.73
- Trulance (Drug) $194.36
- Cimzia (Drug) $180.93
- Creon (Drug) $176.69
- UCERIS (Drug) $172.81
- IBSRELA (Drug) $165.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Fairfield
Dr. Eddy Castillo
Specialist — Payments: $40,030
Dr. Julie Spivack, Md, MD
Specialist — Payments: $13,443
Dr. Emil Blanco, Md, MD
Specialist — Payments: $11,406
Dr. Edward Pinto, Md, MD
Specialist — Payments: $9,438
Dr. Gena Cobrin, Md, MD
Specialist — Payments: $8,930
Dr. Kenneth Mauer, Md, MD
Specialist — Payments: $6,373